[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100506190":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":27,"responsibleParty":45,"collaborators":47,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":10,"enrollmentInfo":60,"targetDuration":10,"studyType":63,"phases":10,"briefSummary":64,"conditions":65,"keywords":10,"overallStatus":30,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"GCS Ramsay Santé pour l'Enseignement et la Recherche","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patient to be treated for a tumor of the pancreas",null,"Patient to be treated for a tumor of the pancreas by ultrasound-guided radiofrequency with a fine needle, with Indication of pancreatic radiofrequency validated in a Multidisciplinary Consultation Meeting",[13],"Procedure: Pancreatic radiofrequency",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"PROCEDURE","Pancreatic radiofrequency","Pancreatic radiofrequency is similar to a puncture under echoendoscopy. The lesion is located then punctured by transgastric or transduodenal route either using a 19 gauge needle with exchange of the stylet for a probe, or using a 19 gauge needle whose distal end of 5-10 mm corresponds to the active part, connected to a generator with an integrated cooling system.",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":25,"email":26},"Bertrand NAPOLEON, MD","CONTACT","428636969","+33","dr.napoleon@wanadoo.fr",[28],{"facility":29,"status":30,"city":31,"state":10,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"CHI Toulon La Seyne","RECRUITING","Toulon","83056","France","FR",{"type":36,"coordinates":37},"Point",[38,39],5.92836,43.12442,{"lat":39,"lon":38},[42],{"name":43,"role":23,"phone":10,"phoneExt":10,"email":44},"Philippe AH-SOUNE, MD","philippe.ah-soune@ch-toulon.fr",{"type":46,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[48],{"name":49,"class":50},"Euraxi Pharma","INDUSTRY","100506190","longitudinal-prospective-french-multicenter-cohort-study-on-pancreatic-radiofrequency-100506190",false,"NCT05871164","Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency","RAFPAN2","Inclusion Criteria:\n\n* Age ≥ 18 years old;\n* Patient to be treated for a pancreatic tumor by ultrasound-guided RF with a fine needle;\n* Indication of pancreatic radiofrequency validated in a Multidisciplinary Consultation Meeting;\n* Patient able to understand the information related to the study;\n* Patient accepting study follow-up visits;\n* Patient having been informed and agreeing to participate in the study.\n\nExclusion Criteria:\n\n* Patient with a contraindication to radiofrequency treatment;\n* Pregnant or breastfeeding women","ALL","18 Years",{"count":61,"type":62},200,"ESTIMATED","OBSERVATIONAL","The purpose of the study is to evaluate the oncological efficacy of pancreatic radiofrequency by the objective response rate (complete and partial responses according to RECIST 1.1.), 5 years after the end of treatment.",[66],"Pancreatic Tumor","2026-03-27",{"date":69,"type":70},"2026-04-01","ACTUAL",{"date":72,"type":70},"2023-06-12",{"date":74,"type":62},"2030-05",{"name":5,"class":6},1]